메뉴 건너뛰기




Volumn 216, Issue 2, 2008, Pages 125-130

Medical history, drug exposure and the risk of psoriasis: Evidence from an Italian case-control study

(21)  Naldi, Luigi a   Chatenoud, Liliane b   Belloni, Anna f   Peserico, Andrea f   Balato, Nicola f   Virgili, Anna Rosa g   Bruni, Pier Luigi h   Ingordo, Vito i   Lo Scocco, Giovanni j   Solaroli, Carmen k   Schena, Donatella l   Di Landro, Anna a   Pezzarossa, Enrico m   Arcangeli, Fabio n   Gianni, Claudia c   Betti, Roberto d   Carli, Paolo o   Farris, Alessandro p   Barabino, Gian Franco q   La Vecchia, Carlo b,e   more..


Author keywords

Case control study; Drug exposure; Psoriasis, comorbidity; Risk factors

Indexed keywords

ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CORTICOSTEROID; DIURETIC AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; LITHIUM SALT; NONSTEROID ANTIINFLAMMATORY AGENT; TRANQUILIZER;

EID: 38549096551     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000111509     Document Type: Article
Times cited : (41)

References (21)
  • 2
    • 33750400902 scopus 로고    scopus 로고
    • Metabolic disorders in patients with psoriasis and psoriatic arthritis
    • Mallbris L, Ritchlin CT, Stahle M: Metabolic disorders in patients with psoriasis and psoriatic arthritis. Curr Rheumatol Rep 2006;8:355-363.
    • (2006) Curr Rheumatol Rep , vol.8 , pp. 355-363
    • Mallbris, L.1    Ritchlin, C.T.2    Stahle, M.3
  • 5
    • 33845465632 scopus 로고    scopus 로고
    • Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients
    • Wakkee M, Thio HB, Prens EP, Sijbrands EJ, Neumann HA: Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients. Atherosclerosis 2007;190:1-9.
    • (2007) Atherosclerosis , vol.190 , pp. 1-9
    • Wakkee, M.1    Thio, H.B.2    Prens, E.P.3    Sijbrands, E.J.4    Neumann, H.A.5
  • 12
    • 28944434431 scopus 로고    scopus 로고
    • Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus
    • Wannamethee SG, Shaper AG, Lennon L, Morris RW: Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med 2005;165:2644-2650.
    • (2005) Arch Intern Med , vol.165 , pp. 2644-2650
    • Wannamethee, S.G.1    Shaper, A.G.2    Lennon, L.3    Morris, R.W.4
  • 15
    • 33645016350 scopus 로고    scopus 로고
    • Psoriasis is associated with lipid abnormalities at the onset of skin disease
    • Mallbris L, Granath F, Hamsten A, Stahle M: Psoriasis is associated with lipid abnormalities at the onset of skin disease. J Am Acad Dermatol 2006;54:614-621.
    • (2006) J Am Acad Dermatol , vol.54 , pp. 614-621
    • Mallbris, L.1    Granath, F.2    Hamsten, A.3    Stahle, M.4
  • 17
    • 33748992313 scopus 로고    scopus 로고
    • Adipocytokines: Mediators linking adipose tissue, inflammation and immunity
    • Tilg H, Moschen AR: Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006;6:772-783.
    • (2006) Nat Rev Immunol , vol.6 , pp. 772-783
    • Tilg, H.1    Moschen, A.R.2
  • 18
    • 32644437182 scopus 로고    scopus 로고
    • Mechanisms of disease: Atherosclerosis in autoimmune diseases
    • Sherer Y, Shoenfeld Y: Mechanisms of disease: atherosclerosis in autoimmune diseases. Nat Clin Pract Rheumatol 2006;2:99-106.
    • (2006) Nat Clin Pract Rheumatol , vol.2 , pp. 99-106
    • Sherer, Y.1    Shoenfeld, Y.2
  • 19
    • 33845866857 scopus 로고    scopus 로고
    • Inflammation and metabolic disorders
    • Hotamisligil GS: Inflammation and metabolic disorders. Nature 2006;444:860-867.
    • (2006) Nature , vol.444 , pp. 860-867
    • Hotamisligil, G.S.1
  • 20
    • 17644376546 scopus 로고    scopus 로고
    • Traditional therapies in the management of moderate to severe chronic plaque psoriasis: An assessment of the benefits and risks
    • Naldi L, Griffiths CE: Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks. Br J Dermatol 2005;152:597-615.
    • (2005) Br J Dermatol , vol.152 , pp. 597-615
    • Naldi, L.1    Griffiths, C.E.2
  • 21
    • 38549127051 scopus 로고    scopus 로고
    • Effects of anti-TNF-alpha treatments on body weight in patients with chronic plaque psoriasis: A retrospective cohort study
    • in press
    • Gisondi P, Cotena C, Tessari G, Girolomoni G: Effects of anti-TNF-alpha treatments on body weight in patients with chronic plaque psoriasis: a retrospective cohort study. J Eur Acad Dermatol Venereol, in press.
    • J Eur Acad Dermatol Venereol
    • Gisondi, P.1    Cotena, C.2    Tessari, G.3    Girolomoni, G.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.